Clinical Aspects of Ankylosing Spondylitis

Ankylosing Spondylitis and the Spondyloarthropathies

Volumn , Issue , 2006, Pages 145-153

  Pang, Shirley W ^a   Davis, John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 42949145725     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03104-2.50016-8     Document Type: Chapter

References (122)

1. Yu DT, Wisenhutter CW Clinical manifestation of ankylosing spondylitis. UpToDate 2004, 12:1.
2. Granfors K, Marker-Hermann E, de Keyser F, Khan MA, Veys EM, Yu DT The cutting edge of spondylarthropathy research in the millennium. Arthritis Rheum. 2002, 46:606-613.
3. Khan MA Clinical features of ankylosing spondylitis. Rheumatology, 3rd ed 2003, 2:1161-1181. Mosby, St. Louis. M. Hochberg, A. Silman, J.S. Smolen (Eds.).
4. Klippel JH, Crofford LJ, Stone JH, Weyland CM Seronegative spondyloarthropathies. Primer on the Rheumatic Diseases. 2001, 251-252. Arthritis Foundation, Atlanta, GA. 12th ed. J.H. Klippel (Ed.).
5. Heuft-Dorenbosch L, van Tubergen A, Spoorenberg A, et al. The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index. Arthritis Rheum. 2004, 51:154-159.
6. Goodman CE, Lange RK, Waxman J, Weiss TE Ankylosing spondylitis in women. Arch Phys Med Rehabil. 1980, 61:167-170.
7. Kidd B, Mullee M, Frank A, Cawley M. Disease expression of ankylosing spondylitis in males and females. J Rheumatol. 1988, 15:1407-1409.
8. Marks SH, Barnett M, Calin A. Ankylosing spondylitis in women and men: a case-control study. J Rheumatol. 1983, 10:624-628.
9. Jimenez-Balderas F, Mintz G. Ankylosing spondylitis: clinical course in women and men. J Rheumatol. 1993, 20:2069-2072.
10. Gran JT, Ostensen M, Husby G. A clinical comparison between males and females with ankylosing spondylitis. J Rheumatol. 1985, 12:126-129.
11. Lee JH, Jun JB, Jung S, et al. Higher prevalence of peripheral arthritis among ankylosing spondylitis patients. J Korean Med Sci. 2002, 17:669-673.
12. Gratacos J, Collado A, Pons F, et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis: a followup study. Arthritis Rheum. 1999, 42:2319-2324.
13. El Maghraoui A, Bordene D, Cherruau B, et al. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol. 1999, 26:2205-2209.
14. Maillefert JF, Aho LS, El Maghaoui A, Dougados M, Roux C. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int. 2001, 12:605-609.
15. Cooper C, Carbone L, Michet CJ, Atkinson EJ, O'Fallon WM, Melton LJ Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol. 1994, 21:1877-1882.
16. Meirelles ES, Borelli A, Camargo OP Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol. 1999, 18:364-368.
17. Wakefield D, Montanaro A, McCluskey P. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 1991, 36:223-232.
18. Maksymowych WP, Chou CT, Russell AS Matching prevalence of peripheral arthritis and acute anterior uveitis in individuals with ankylosing spondylitis. Ann Rheum Dis. 1995, 54:128-130.
19. Rothova A, van Veenedaal WG, Linssen A, Glasius E, Kijlstra A, de Jong PT Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987, 103:137-145.
20. Monnet D, Breban M, Hudry C, Dougados M, Brezin AP Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology. 2004, 111:802-809.
21. Tay-Kearney ML, Schwam BL, Lowder C, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996, 121:47-56.
22. Hantzschel H, Otto W, Romhild N, et al. Characteristics of the early phase of ankylosing spondylitis. Z Gesamte Inn Med. 1981, 36:189-192.
23. Amor B, Santos RS, Nahal R, Listat V, Dougados M. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol. 1994, 21:1883-1887.
24. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kiljstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996, 80:332-336.
25. Rodriguez A, Akova YA, Pedroza-Seres M, Foster CS Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology. 1994, 101:1267-1274.
26. Dodds EM, Lowder CY, Meisler DM Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics. Ocul Immunol Inflamm. 1999, 7:85-92.
27. Rothova A. Comment on 'Posterior segment inflammation in HLA-B27+ acute anterior uveitis: clinical characteristics'. Ocul Immunol Inflamm 2000, 8:73-75.
28. Roldan CA Valvular disease associated with systemic illness. Cardiol Clin. 1998, 16:531-550.
29. Bulkley BH, Roberts WC Ankylosing spondylitis and aortic regurgitation Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation. 1973, 48:1014-1027.
30. Davidson P, Baggenstoss AH, Slocumb CH, Daugherty GW Cardiac and aortic lesions in rheumatoid spondylitis. Mayo Clin Proc. 1963, 38:427-435.
31. Gupta BK, Panwar RB, Kabra PK, Kaushik AN, Meena GL, Chadda VS Ankylosing spondylitis in association with mitral stenosis, mitral regurgitation, and aortic regurgitation: a case report and review of the literature. Echocardiography. 2003, 20:275-277.
32. Roldan CA, Chavez J, Weist PW, Qualls CR, Crawford MH Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol. 1998, 32:1397-1404.
33. Graham DC, Smythe HA The carditis and aortitis of ankylosing spondylitis. Bull Rheum Dis. 1958, 9:171-174.
34. O'Neill TW, King G, Graham IM, Molony J, Bresnihan B. Echocardiographic abnormalities in ankylosing spondylitis. Ann Rheum Dis. 1992, 51:652-654.
35. Alves MG, Espirito-Santo J, Queiroz MV, Madeira H, MacieiraCoelho E. Cardiac alterations in ankylosing spondylitis. Angiology 1988, 39(7 Pt 1):567-571.
36. Tucker CR, Fowles RE, Calin A, Popp RL Aortitis in ankylosing spondylitis: early detection of aortic root abnormalities with two dimensional echocardiography. Am J Cardiol. 1982, 49:680-686.
37. Kinsella T, Johnson LG, Ian R. Cardiovascular manifestations of ankylosing spondylitis. Can Med Assoc J. 1974, 111:1309-1311.
38. Bachmann F, Hartl W, Veress M, Frind W. Cardiovascular complications of ankylosing spondylitis (Bechterew's disease). Med Welt. 1976, 27:2149-2150.
39. Porciello PI, Capella G, Aralda D, Rossi P. Mitral and aortic regurgitation: a rare association in ankylosing spondylitis (author's transl). G Ital Cardiol. 1978, 8:564-567.
40. Berstein L, Broch O. Cardiac complications in spondylarthritis ankylopoietica. Acta Med Scand. 1949, 135:185-194.
41. Bergfeldt L, Edhag O, Vallin H. Cardiac conduction disturbances, an underestimated manifestation in ankylosing spondylitis A 25-year follow-up study of 68 patients. Acta Med Scand. 1982, 212:217-223.
42. Cass RM, Richeson JF, Akiyama T. Reversible complete heart block. Hosp Pract (OffEd) 1991, 26:51.
43. Sukenik S, Pras A, Buskila D, Katz A, Snir Y, Horowitz J. Cardiovascular manifestations of ankylosing spondylitis. Clin Rheumatol. 1987, 6:588-592.
44. Weed CL, Kulander BG, Massarella JA, Decker JL Heart block in ankylosing spondylitis. Arch Intern Med. 1966, 117:800-806.
45. Bergfeldt L, Vallin H, Edhag O. Complete heart block in HLA-B27 associated disease Electrophysiological and clinical characteristics. Br Heart J. 1984, 51:184-188.
46. Nitter-Hauge S, Otterstad JE Characteristics of atrioventricular conduction disturbances in ankylosing spondylitis (Mb. Bechterew). Acta Med Scand. 1981, 210:197-200.
47. Bergfeldt L, Allebeck P, Edhag O. Mortality in pacemakertreated patients A follow-up study of the impact of HLA-B27 and associated rheumatic disorders. Acta Med Scand. 1987, 222:293-299.
48. Nagyhegyi G, Nadas I, Banyai F, et al. Cardiac and cardiopulmonary disorders in patients with ankylosing spondylitis and rheumatoid arthritis. Clin Exp Rheumatol. 1988, 6:17-26.
49. Crowley JJ, Donnelly SM, Tobin M, et al. Doppler echocardiographic evidence of left ventricular diastolic dysfunction in ankylosing spondylitis. Am J Cardiol. 1993, 71:1337-1340.
50. Sun JP, Khan MA, Farhat AZ, Bahler RC Alterations in cardiac diastolic function in patients with ankylosing spondylitis. Int J Cardiol. 1992, 37:65-72.
51. Bergfeldt L, Edhag O, Rajs J. HLA-B27-associated heart disease. Clinicopathologic study of three cases. Am J Med. 1984, 77:961-967.
52. Bergfeldt L. HLA-B27-associated cardiac disease. Ann Intern Med 1997, 127(8 Pt 1):621-629.
53. Bergfeldt L. HLA-B27-associated rheumatic diseases with severe cardiac bradyarrhythmias. Clinical features and prevalence in 223 men with permanent pacemakers. Am J Med. 1983, 75:210-215.
54. Bergfeldt L, Edhag O, Vedin L, Vallin H. Ankylosing spondylitis: an important cause of severe disturbances of the cardiac conduction system Prevalence among 223 pacemaker-treated men. Am J Med. 1982, 73:187-191.
55. Bergfeldt L, Insulander P, Lindblom D, Moller E, Edhag O. HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities. Am J Med. 1988, 85:12-18.
56. Qaiyumi S, Hassan ZU, Toone E. Seronegative spondyloarthropathies in lone aortic insufficiency. Arch Intern Med. 1985, 145:822-824.
57. Libby DM, Schley WS, Smith JP Cricoarytenoid arthritis in ankylosing spondylitis A cause of acute respiratory failure and cor pulmonale. Chest. 1981, 80:641-642.
58. Fournie B, Boutes A, Dromer C, et al. Prospective study of anterior chest wall involvement in ankylosing spondylitis and psoriatic arthritis. Rev Rhum Engl Ed. 1997, 64:22-25.
59. Wiedemann HP, Matthay RA Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med. 1989, 10:677-722.
60. Feltelius N, Hedenstrom H, Hillerdal G, Hallgren R. Pulmonary involvement in ankylosing spondylitis. Ann Rheum Dis. 1986, 45:736-740.
61. Franssen MJ, van Herwaarden CL, van de Putte LB, Gribnau FW Lung function in patients with ankylosing spondylitis. A study of the influence of disease activity and treatment with nonsteroidal antiinflammatory drugs. J Rheumatol. 1986, 13:936-940.
62. Hunninghake GW, Fauci AS Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis. 1979, 119:471-503.
63. Tanoue LT Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjögren's syndrome, and relapsing polychondritis. J Thorac Imaging. 1992, 7:62-77.
64. Dunham CL, Kautz F. Spondylarthritis ankylopoietica: a review and report of twenty cases. Am J Med Sci. 1941, 201:232-250.
65. Hamilton K. Pulmonary disease manifestations of ankylosing spondylarthritis. Ann Intern Med. 1949, 31:216-227.
66. Rosenow E, Strimlan CV, Muhm JR, Ferguson RH Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc. 1977, 52:641-649.
67. Thai D, Ratani RS, Salame S, Steiner RM Upper lobe fibrocavitary disease in a patient with back pain and stiffness. Chest. 2000, 118:1814-1816.
68. Lee-Chiong TL Pulmonary manifestations of ankylosing spondylitis and relapsing polychondritis. Clin Chest Med 1998, 19:747-757. ix.
69. Wolson AH, Rohwedder JJ Upper lobe fibrosis in ankylosing spondylitis. Am J Roentgenol Radium Ther Nucl Med. 1975, 124:466-471.
70. Gupta SM, Johnston WH Apical pulmonary disease in ankylosing spondylitis. NZ Med J. 1978, 88:186-188.
71. Rumancik WM, Firooznia H, Davis MS, et al. Fibrobullous disease of the upper lobes: an extraskeletal manifestation of ankylosing spondylitis. J Comput Tomogr. 1984, 8:225-229.
72. Ferdoutsis M, Bouros D, Meletis G, Patsourakis G, Siafakas NM Diffuse interstitial lung disease as an early manifestation of ankylosing spondylitis. Respiration. 1995, 62:286-289.
73. Boulware DW, Weissman DN, Doll NJ Pulmonary manifestations of the rheumatic diseases. Clin Rev Allergy. 1985, 3:249-267.
74. Campbell AH, Macdonald CB Upper lobe fibrosis associated with ankylosing spondylitis. Br J Dis Chest. 1965, 59:90-101.
75. Fenlon HM, Casserly I, Sant SM, Breatnach E. Plain radiographs and thoracic high-resolution CT in patients with ankylosing spondylitis. AJR Am J Roentgenol. 1997, 168:1067-1072.
76. Stewart RM, Ridyard JB, Pearson JD Regional lung function in ankylosing spondylitis. Thorax. 1976, 31:433-437.
77. Scobie BA Disturbed oesophageal manometric responses in patients with ankylosing spondylitis and pulmonary aspergilloma. Australas Ann Med. 1970, 19:131-134.
78. Casserly IP, Fenlon HM, Breatnach E, Sant SM Lung findings on high-resolution computed tomography in idiopathic ankylosing spondylitis---correlation with clinical findings, pulmonary function testing and plain radiography. Br J Rheumatol. 1997, 36:677-682.
79. Primack SL, Muller NL Radiologic manifestations of the systemic autoimmune diseases. Clin Chest Med 1998, 19:573-586. vii.
80. Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol. 1996, 25:138-142.
81. Strobel ES, Fritschka E. Renal diseases in ankylosing spondylitis: review of the literature illustrated by case reports. Clin Rheumatol. 1998, 17:524-530.
82. Gratacos J, Orellana C, Sanmarti R, et al. Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration. J Rheumatol. 1997, 24:912-915.
83. Lai KN, Li PK, Hawkins B, Lai FM IgA nephropathy associated with ankylosing spondylitis: occurrence in women as well as in men. Ann Rheum Dis. 1989, 48:435-437.
84. Vilar MJ, Cury SE, Ferraz MB, Sesso R, Atra E. Renal abnormalities in ankylosing spondylitis. Scand J Rheumatol. 1997, 26:19-23.
85. Ozgocmen S, Kocakoc E, Kiris A, Ardicoglu A, Ardicoglu O. Incidence of varicoceles in patients with ankylosing spondylitis evaluated by physical examination and color duplex sonography. Urology. 2002, 59:919-922.
86. Pirildar T, Muezzinoglu T, Pirildar S. Sexual function in ankylosing spondylitis: a study of 65 men. J Urol. 2004, 171:1598-1600.
87. Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol. 1998, 18:1386-1392.
88. Haagsma CJ, Blom HJ, van Riel PL, et al. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis. 1999, 58:79-84.
89. Fisher S. Body Images and Personality. 1968, 363-375. Dover Publications, New York, NY. 2nd ed.
90. Elst P, Sybesma T, van der Stadt RJ, Prins AP, Muller WH, den Butter A. Sexual problems in rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 1984, 27:217-220.
91. Karasick D, Schweitzer ME, Abidi NA, Cotler JM Fractures of the vertebrae with spinal cord injuries in patients with ankylosing spondylitis: imaging findings. AJR Am J Roentgenol. 1995, 165:1205-1208.
92. Ralston SH, Urquhart GD, Brzeski M, Sturrock RD Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ. 1990, 300:563-565.
93. Taggard DA, Traynelis VC Management of cervical spinal fractures in ankylosing spondylitis with posterior fixation. Spine. 2000, 25:2035-2039.
94. Weinstein PR, Karpman RR, Gall EP, Pitt M. Spinal cord injury, spinal fracture, and spinal stenosis in ankylosing spondylitis. J Neurosurg. 1982, 57:609-616.
95. Murray GC, Persellin RH Cervical fracture complicating ankylosing spondylitis: a report of eight cases and review of the literature. Am J Med. 1981, 70:1033-1041.
96. Bohlmann H. Acute fractures and dislocations of the cervical spine: an analysis of 300 hospitalized patients and review of the literature. J Bone Joint Surg Am. 1979, 61:1119-1142.
97. Bennett DL, Ohashi K, El-Khoury GY Spondyloarthropathies: ankylosing spondylitis and psoriatic arthritis. Radiol Clin North Am. 2004, 42:121-134.
98. Ramos-Remus C, Gomez-Vargas A, Hernandez-Chavez A, et al. Two year followup of anterior and vertical atlantoaxial subluxation in ankylosing spondylitis. J Rheumatol. 1997, 24:507-510.
99. Bartleson JD, Cohen MD, Harrington TM, Goldstein NP, Ginsburg WW Cauda equina syndrome secondary to longstanding ankylosing spondylitis. Ann Neurol. 1983, 14:662-669.
100. Sant SM, O'Connell D. Cauda equina syndrome in ankylosing spondylitis: a case report and review of the literature. Clin Rheumatol. 1995, 14:224-226.
101. Libbrecht N, De Bleecker J. Ankylosing spondylitis and multiple sclerosis. Acta Clin Belg. 1999, 54:30-32.
102. Oh D, Jun JB, Kim HT, Lee SW, Jung SS, Lee IH, Kim SY Transverse myelitis in a patient with long-standing ankylosing spondylitis. Clin Exp Rheumatol. 2001, 19:195-197.
103. Cellerini M, Gabbrielli S, Bongi SM Cerebral magnetic resonance imaging in a patient with ankylosing spondylitis and multiple sclerosis-like syndrome. Neuroradiology. 2001, 43:1067-1069.
104. Thompson AJ, Miller D, Youl B, et al. Serial gadoliniumenhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology. 1992, 42:60-63.
105. Whitman GJ, Khan MA Unusual occurrence of ankylosing spondylitis and multiple sclerosis in a black patient. Cleve Clin J Med. 1989, 56:819-822.
106. Hanrahan PS, Russell AS, McLean DR Ankylosing spondylitis and multiple sclerosis: an apparent association?. J Rheumatol 1988, 15:1512-1514.
107. Thomson G. HLA disease associations: models for the study of complex human genetic disorders. Crit Rev Clin Lab Sci. 1995, 32:183-219.
108. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today. 1990, 11:137-142.
109. Ebers GC, Bulman DE, Sadovnick AD, et al. A population-based study of multiple sclerosis in twins. N Engl J Med. 1986, 315:1638-1642.
110. Mielants H, Veys EM, Cuvelier C, De Vos M. Course of gut inflammation in spondylarthropathies and therapeutic consequences. Baillieres Clin Rheumatol. 1996, 10:147-164.
111. Mielants H, Veys EM, Goemaere S, Goethals K, Cuvelier C, De Vos M. Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study. J Rheumatol. 1991, 18:1542-1551.
112. Mielants H, Veys EM, Joos R, Cuvelier C, De Vos M. Repeat ileocolonoscopy in reactive arthritis. J Rheumatol. 1987, 14:456-458.
113. Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppala K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum. 1994, 37:23-31.
114. Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I. Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum. 2001, 44:2728-2736.
115. De Keyser F, Elewaut D, De Vos M, et al. Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin North Am 1998, 24:785-813. ix-x.
116. Mielants H, Veys EM, Cuvelier C, et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol. 1995, 22:2279-2284.
117. De Vos M, Cuvelier C, Mielants H, Veys E, Barbier F, Elewaut A. Ileocolonoscopy in seronegative spondylarthropathy. Gastroenterology 1989, 96(2 Pt 1):339-444.
118. De Keyser F, Mielants H. The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface. J Rheumatol. 1998, 30:2306-2307.
119. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984, 27:361-368.
120. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994, 21:2286-2291.
121. Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?. Rheumatology (Oxford) 1999, 38:878-882.
122. Dougados M, van der Heijde D. Ankylosing spondylitis: how should the disease be assessed?. Best Pract Res Clin Rheumatol 2002, 16:605-618.